Beauty Farm Medical and Health Industry Inc. (Hong Kong-listed, stock code 02373) disclosed a share buyback executed on 17 June 2026 under its approved repurchase mandate.

The company bought back 60,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$17.65 to HK$18.10, with a volume-weighted average purchase price of HK$17.9703. Aggregate consideration amounted to HK$1.08 million. All repurchased shares are being held as treasury stock.

Capital structure impact • Issued shares (excluding treasury shares) fell marginally by 0.0241% to 248.78 million. • Treasury shares increased to 2.81 million, bringing total shares in issue to 251.59 million, unchanged overall.

Repurchase mandate utilisation • The buyback was made under the mandate approved on 27 June 2025, which authorises repurchases of up to 23.58 million shares. • Cumulative repurchases under this mandate now total 2.81 million shares, equivalent to 1.19% of the company’s share base at the mandate date. • Approximately 20.77 million shares remain available for repurchase. • In line with Hong Kong listing rules, Beauty Farm Medical is restricted from issuing new shares or selling treasury shares until 17 July 2026.

The board confirmed that the transaction complied with all applicable regulatory requirements.